Literature DB >> 14965598

Pre-operative estimation of primary breast cancer size: a comparison of clinical assessment, mammography and ultrasound.

S A Allen1, W J Cunliffe, J Gray, J E Liston, L G Lunt, L A Webb, J R Young.   

Abstract

This prospective study aimed to determine which is the most precise modality for the pre-operative measurement of primary breast cancers: clinical palpation; mammography; or ultrasound. Analysis of the difference between the measurement of the maximum tumour diameter by these three modalities and by the histological measurement was performed in 210 cases. Clinical palpation tended to overestimate tumour size and gave the largest standard deviation of the difference. Ultrasound and mammography both gave a similar standard deviation of the difference, with ultrasound tending to underestimate tumour size. For all modalities, the standard deviation and the 95% confidence intervals of the difference increased with increasing tumour size. There is little difference between the precision of ultrasound and mammography in measuring tumour size. The wide 95% confidence intervals for any method of pre-operative tumour measurement should be considered when planning patient management.

Entities:  

Year:  2001        PMID: 14965598     DOI: 10.1054/brst.2000.0255

Source DB:  PubMed          Journal:  Breast        ISSN: 0960-9776            Impact factor:   4.380


  4 in total

1.  Contrast-enhanced spectral mammography versus MRI: Initial results in the detection of breast cancer and assessment of tumour size.

Authors:  E M Fallenberg; C Dromain; F Diekmann; F Engelken; M Krohn; J M Singh; B Ingold-Heppner; K J Winzer; U Bick; D M Renz
Journal:  Eur Radiol       Date:  2013-09-19       Impact factor: 5.315

2.  A model study of 3-dimensional localization of breast tumors using piezoelectric fingers of different probe sizes.

Authors:  Xin Xu; Wei-Heng Shih; Wan Y Shih
Journal:  Rev Sci Instrum       Date:  2019-01       Impact factor: 1.523

3.  Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer.

Authors:  R J Burcombe; A Makris; P I Richman; F M Daley; S Noble; M Pittam; D Wright; S A Allen; J Dove; G D Wilson
Journal:  Br J Cancer       Date:  2005-01-17       Impact factor: 7.640

4.  Accuracy of contrast-enhanced breast ultrasound for pre-operative tumor size assessment in patients diagnosed with invasive ductal carcinoma of the breast.

Authors:  S van Esser; W B Veldhuis; R van Hillegersberg; P J van Diest; G Stapper; M ElOuamari; I H M Borel Rinkes; W P Th M Mali; M A A J van den Bosch
Journal:  Cancer Imaging       Date:  2007-05-15       Impact factor: 3.909

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.